These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3008985

  • 21. N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
    Hidaka H, Sasaki Y, Tanaka T, Endo T, Ohno S, Fujii Y, Nagata T.
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4354-7. PubMed ID: 6945588
    [Abstract] [Full Text] [Related]

  • 22. Symmetric covalent linkage of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) results in novel derivatives with increased inhibitory activities against calcium/calmodulin complex.
    Yokokura H, Osawa M, Inoue T, Umezawa I, Naito Y, Ikura M, Hidaka H.
    Drug Des Discov; 1999 Nov; 16(3):203-16. PubMed ID: 10624566
    [Abstract] [Full Text] [Related]

  • 23. Alteration in insulin receptor expression accompanying differentiation of HL-60 leukemia cells.
    Chaplinski TJ, Bennett TE, Caro JF.
    Cancer Res; 1986 Mar; 46(3):1203-7. PubMed ID: 3002611
    [Abstract] [Full Text] [Related]

  • 24. Lack of correlation between induction of chemotactic peptide receptors and stimulus-induced actin polymerization in HL-60 cells treated with dibutyryl cyclic adenosine monophosphate or retinoic acid.
    Rao KM, Currie MS, Ruff JC, Cohen HJ.
    Cancer Res; 1988 Dec 01; 48(23):6721-6. PubMed ID: 2846157
    [Abstract] [Full Text] [Related]

  • 25. Increment of calmodulin in proportion to enhancement of non-nicotinic responses after preganglionic stimulation of the dog cardiac sympathetic ganglia.
    Kushiku K, Araki Y, Furukawa T, Iwasa T, Inoue N, Miyamoto E.
    J Pharmacol Exp Ther; 1988 Apr 01; 245(1):311-8. PubMed ID: 2896238
    [Abstract] [Full Text] [Related]

  • 26. Effects of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide and other calmodulin antagonists (calmodulin interacting agents) on calcium-induced contraction of rabbit aortic strips.
    Kanamori M, Naka M, Asano M, Hidaka H.
    J Pharmacol Exp Ther; 1981 May 01; 217(2):494-9. PubMed ID: 6453220
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition of histamine release from human basophils in vitro by calmodulin antagonists.
    Marone G, Columbo M, Poto S, Condorelli M.
    Clin Immunol Immunopathol; 1983 Sep 01; 28(3):334-40. PubMed ID: 6192958
    [Abstract] [Full Text] [Related]

  • 28. Effects of calmodulin antagonists on immune mouse lymphocytes.
    Wolberg G, Zimmerman TP.
    Mol Pharmacol; 1984 Sep 01; 26(2):286-92. PubMed ID: 6482875
    [Abstract] [Full Text] [Related]

  • 29. Induction of functional differentiation of a human monocytic leukemia cell line (THP-1) by retinoic acid and cholera toxin.
    Hemmi H, Breitman TR.
    Jpn J Cancer Res; 1985 May 01; 76(5):345-51. PubMed ID: 2989063
    [Abstract] [Full Text] [Related]

  • 30. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing agents.
    Olsson IL, Breitman TR.
    Cancer Res; 1982 Oct 01; 42(10):3924-7. PubMed ID: 6286100
    [Abstract] [Full Text] [Related]

  • 31. Loss of alpha 2-macroglobulin and epidermal growth factor surface binding induced by phenothiazines and naphthalene sulfonamides.
    DiPaola M, Keith CH, Feldman D, Tycko B, Maxfield FR.
    J Cell Physiol; 1984 Feb 01; 118(2):193-202. PubMed ID: 6319437
    [Abstract] [Full Text] [Related]

  • 32. Effect of calmodulin inhibitors on thyroid hormone secretion.
    Nakai A, Nagasaka A, Hidaka H, Tanaka T, Ohyama T, Iwase K, Ohtani S, Shinoda S, Aono T, Masunaga R.
    Endocrinology; 1986 Nov 01; 119(5):2279-83. PubMed ID: 3021438
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effects of calmodulin antagonists on calcium pump and cytosolic calcium level in human neutrophils.
    Capuozzo E, Verginelli D, Crifò C, Salerno C.
    Biochim Biophys Acta; 1997 Jun 05; 1357(1):123-7. PubMed ID: 9202183
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of dimaprit on growth and differentiation of human promyelocytic cell line, HL-60.
    Kalinyak KA, Sawutz DG, Lampkin BC, Johnson CL, Whitsett JA.
    Life Sci; 1985 May 20; 36(20):1909-16. PubMed ID: 2985904
    [Abstract] [Full Text] [Related]

  • 37. The many faces of calmodulin in cell proliferation, programmed cell death, autophagy, and cancer.
    Berchtold MW, Villalobo A.
    Biochim Biophys Acta; 2014 Feb 20; 1843(2):398-435. PubMed ID: 24188867
    [Abstract] [Full Text] [Related]

  • 38. Retinoic acid-induced expression of tissue transglutaminase in human promyelocytic leukemia (HL-60) cells.
    Davies PJ, Murtaugh MP, Moore WT, Johnson GS, Lucas D.
    J Biol Chem; 1985 Apr 25; 260(8):5166-74. PubMed ID: 2859286
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Enhancement of the cAMP-induced apolipoprotein-mediated cellular lipid release by calmodulin inhibitors W7 and W5 from RAW 264 mouse macrophage cell line cells.
    Suzuki S, Abe-Dohmae S, Fukutomi T, Ito S, Itoh M, Yokoyama S.
    J Cardiovasc Pharmacol; 2000 Nov 25; 36(5):609-16. PubMed ID: 11065221
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.